Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury

Launched by RIGSHOSPITALET, DENMARK · Aug 16, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at patients who have experienced severe acute brain injuries, such as traumatic brain injury, strokes, or other serious conditions. The main goal of the study is to understand how high blood sugar levels (hyperglycemia) and high levels of lactic acid (hyperlactatemia) develop in these patients and how they affect recovery. Some participants will also have special tests to explore the relationship between blood sugar levels and the brain's sugar and lactate levels.

To participate, individuals need to be at least 18 years old and admitted to the neurointensive care unit at Rigshospitalet with a diagnosis of acute brain injury. Unfortunately, patients who are declared brain dead before joining the study or whose closest relatives do not speak Danish or English will not be eligible. Those who take part can expect to contribute to important research that could help improve understanding and treatment for future patients with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Admission to the neurointensive care unit at Rigshospitalet
• • Diagnosis of acute brain injury categorised as TBI, SAH, ICH, ischaemic stroke, or other conditions
• Exclusion Criteria:
• • Brain death before inclusion
• • Closest relatives do not understand written and spoken Danish or English